FDA Inspection
CBR Systems IncCBR Systems Inc – FDA Inspection, Jan 17, 2024
Record Details
This FDA Inspection record concerns CBR Systems Inc, with an inspection on January 17, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · bf6a56c5-e6a7-48c9-be46-ca8c2315b04b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227528
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
5- 21 CFR 1271.265(d)Shipping conditions appropriate
- 21 CFR 1271.160(d)Documentation/approval prior to implementation
- 21 CFR 1271.195(a)Adequate control, proper conditions
- 21 CFR 1271.250(b)Verification of label accuracy, legibility, integrity
- 21 CFR 1271.210(a)Use prior to verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CBR Systems Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 14, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 14, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 3, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CBR Systems Inc
- FDA Inspection 1259463 - 2025-01-17
- FDA Inspection 1068670 - 2018-09-14
- FDA Inspection 785859 - 2012-06-14
- FDA Inspection 584441 - 2009-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.